Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] SK hynix(000660) – Change in Revenue or Loss/Profit Structure Exceeding 30% (15% for Large Corporations) / 2024-01-25

Posted on January 25, 2024July 29, 2026 By K-STOCK Editor No Comments on [Disclosure] SK hynix(000660) – Change in Revenue or Loss/Profit Structure Exceeding 30% (15% for Large Corporations) / 2024-01-25

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Due to weak demand for memory semiconductors and a sharp drop in prices, SK hynix’s consolidated revenue for FY2023 dropped 26.6% year-over-year to KRW 32.77T, with operating profit and net profit turning into losses.

📊 [Key Disclosure Details & Financial Summary]

  • Classification & Corporate Status
    • Financial Statement Type: Consolidated Financial Statements
    • Large Corporation Status: Applicable
  • Revenue and Profit/Loss Performance (Unit: KRW)
    • Revenue: KRW 32.77T (KRW 32,765,719,000,000 / YoY Change: -26.6%)
    • Operating Profit/Loss: KRW -7.73T (KRW -7,730,313,000,000 / Turned to Loss)
    • Pre-tax Profit/Loss from Continuing Operations: KRW -11.66T (KRW -11,657,816,000,000 / Turned to Loss)
    • Net Profit/Loss: KRW -9.14T (KRW -9,137,547,000,000 / Turned to Loss)
  • Financial Position Overview (Unit: KRW)
    • Total Assets: KRW 100.33T (KRW 100,330,165,000,000)
    • Total Liabilities: KRW 46.83T (KRW 46,826,413,000,000)
    • Total Equity: KRW 53.50T (KRW 53,503,752,000,000) (Capital Stock: KRW 3.66T)
    • Equity Excl. Non-controlling Interests: KRW 53.50T (KRW 53,504,285,000,000)
    • Separate Revenue: KRW 27.64T (KRW 27,639,997,000,000)
  • Key Reasons for Change & Board Resolution
    • Primary Reason: Profit decline due to weak memory demand and sharp price drops
    • Board Resolution Date: January 24, 2024 (7 Independent Directors attended, 0 absent)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Preliminary Earnings Against Final Audit Report Figures

This disclosure reflects preliminary consolidated financial performance prepared prior to the completion of external audit procedures. Verifying whether these preliminary revenue and operating loss figures remain unchanged in the final audit process is crucial for assessing financial data accuracy. Final audited results can be verified in the upcoming ‘Submission of Audit Report’ disclosure and the ‘Financial Statements’ section of the Annual Report.

📢 Disclaimer & Fact Source

Source: This content was newly generated and structured based on official disclosure data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy/sell specific stocks. All investment decisions and financial responsibilities lie entirely with the investor.

Contact Us: For compliance queries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] SK hynix(000660) – Decision on Disposal of Treasury Shares / 2024-01-25
Next Post: [Disclosure] SK hynix(000660) – Decision on Cash and In-Kind Dividend / 2024-01-25

Related Posts

[Disclosure] Hanwha Ocean (042660) – Major Management Matters Related to Investment Decisions / 2026-01-27 Disclosures
[Disclosure] Samsung Biologics (207940) – Single Sales and Supply Contract / 2024-11-20 Disclosures
[Disclosure] SK Hynix (000660) – Decision on Capital Increase (Correction) / 2026-07-10 Disclosures
[Disclosure] Samsung Biologics (207940) – Consolidated Financial Results (Preliminary) / 2026-07-23 Disclosures
[Disclosure] Samsung Biologics (207940) – Outlook on Operating Results Based on Consolidated Financial Statements (Fair Disclosure) / 2025-01-22 Disclosures
[Disclosure] PSK Holdings (031980) – Setting of Record Date or Closure Period of Shareholder Register / 2023-12-15 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme